Global Drug of Abuse (DOA) Testing Market – Analysis and Forecast (2018-2024)

Page 1

Get in Touch: 1-888-253-3960 enquiry@vynzresearch.com

Global Drug of Abuse (DOA) Testing Market © 2018 VynZ Research All rights reserved


About VynZ Research… VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. 

VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved.

A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts.

Serving wide range of customers most of them from Fortune 2000 companies

With a dedicated 24x7 customer helpline our customers can reach for specifying their needs

Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.

© 2018 VynZ Research All rights reserved


Drug of Abuse (DOA) Testing Market

Drug of Abuse (DOA) testing is the clinical detection of one or more drugs within the human system, by sample testing. This is done to provide clinical intervention or for monitoring of illegal drug intake. Global DOA testing market was poised at USD 4,938.6 million in 2017. The testing for DOA requires products such as immunoassay analyzers, chromatography instruments, breath analyzers, rapid test kits, and assay kits & reagents. The rapid test kits are driving the growth of the DOA testing market and are estimated to hold the largest share in 2017. Š 2018 VynZ Research All rights reserved


Drug of Abuse (DOA) Testing Market The increase in production, consumption and trade for new and illicit drugs will lead to high demand of DOA testing that will drive the growth of industry. According to the World Drug Report 2017 by UNODC, the annual prevalence of all illicit drug use is 5.3% with 255 million numbers of users in 2015. This will necessitate the need for DOA testing and will thereby drive the growth of the market. The government initiatives to raise awareness against DOA and rise in organizational compliance for DOA testing will render to the growth of the overall market. Geographically, North America accounts for the largest share in the DOA testing market, globally. This contribution is due to the adaptation of technologically advanced products for DOA testing, increased demand for illicit drugs in the region, large scale drug trafficking, and the increasing government initiative to spread awareness against DOA. Moreover, the DOA testing industry is expected to be witness the fastest growth in Asia-Pacific. Š 2018 VynZ Research All rights reserved


Drug of Abuse (DOA) Testing Market The major player in the global DOA testing market includes Danaher Corporation, Siemens AG, Merck KGaA, Drägerwerk AG & Co. KGaA, bioMérieux S.A., Waters Corporation, F. Hoffmann-La Roche AG, Quest Diagnostics Inc., Laboratory Corporation of America Holdings, Abbott Laboratories, ThermoFisher Scientific Inc., Express Diagnostics Int'l, Inc., Randox Laboratories Ltd., Psychemedics Corporation, and Bio-Rad Laboratories, Inc. The leading players through acquisitions are attaining competency and larger market share in the global DOA testing industry. For example, in January 2018, ACM Global Laboratories, an affiliate of Rochester Regional Health announced the strategic acquisition of DrugScan, Inc. and DSI Medical Services, Inc. The acquisition was made to establish a laboratory service portfolio and drug testing capabilities. © 2018 VynZ Research All rights reserved


For Sample Report :https:// www.vynzresearch.com/healthcare/drug-of-abuse-doa-testing-market/request-samp le

www.vynzresearch.com

Š 2018 VynZ Research All rights reserved


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.